INSUBCONTINENT EXCLUSIVE:
Manas Jaiswal of manasjaiswal.com has a buy call on Aurobindo Pharma Ltd
with a target price of Rs 515.0
The current price of Aurobindo Pharma Ltd
Manas Jaiswal recommended to keep a stoploss at Rs 484
Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 28889.70 Crore) operating in
key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11922.63 Crore to Sales Value (97.26 % of Total Sales),
Pharmaceuticals which contributed Rs 11922.63 Crore to Sales Value (97.26 % of Total Sales), Pharmaceuticals which contributed Rs 11922.63
Crore to Sales Value (97.26 % of Total Sales), Export Incentives which contributed Rs 303.72 Crore to Sales Value (2.47 % of Total Sales),
Export Incentives which contributed Rs 303.72 Crore to Sales Value (2.47 % of Total Sales), Export Incentives which contributed Rs 303.72
Crore to Sales Value (2.47 % of Total Sales), Sale of services which contributed Rs 16.07 Crore to Sales Value (0.13 % of Total Sales), Sale
of services which contributed Rs 16.07 Crore to Sales Value (0.13 % of Total Sales), Sale of services which contributed Rs 16.07 Crore to
Sales Value (0.13 % of Total Sales), Scrap which contributed Rs 15.47 Crore to Sales Value (0.12 % of Total Sales), Scrap which contributed
Rs 15.47 Crore to Sales Value (0.12 % of Total Sales) and Scrap which contributed Rs 15.47 Crore to Sales Value (0.12 % of Total Sales)for
the year ending 31-Mar-2019
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 5518.27 Crore, unchanged .00 % from last quarter
Sales of Rs Crore and unchanged .00 % from last year same quarter Sales of Rs Crore Company has reported net profit after tax of Rs 639.46
Murthy, Mr.M Madan Mohan Reddy, Mr.K Ragunathan, Mr.K Nithyananda Reddy, Dr.(Mrs.)Avnit Bimal Singh, Mrs.Savita Mahajan
Company has BSR - Associates LLP as its auditoRs As on 31-12-2019, the company has a total of 585,938,609 shares outstanding.